Report post
In-depth analysis of Baxter International stock reveals a strategist's bullish view, advising a buy over Eli Lilly. Baxter CEO sheds light on factors driving stock to new highs. However, caution is urged due to accounting irregularities, potentially necessitating a stock sale, as per Jim Cramer's advice. Investors must weigh these factors carefully.

The World's Leading Crypto Trading Platform

Get my welcome gifts